Bupivacaine Hydrochloride (Grace Therapeutics)

N/A

Report date: 2025/05/15 15:30:46

Base Information

Drug NameBupivacaine Hydrochloride (Grace Therapeutics)
Drug Alias NameBupivacaine HCl metered spray (Grace Therapeutics)GTx-101GTx101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGrace Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia, Postherpetic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A